Invokamet (canagliflozin and metformin hydrochloride) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) March 2016 CONTRAINDICATIONS History of a serious hypersensitivity reaction to canagliflozin or metformin, such as anaphylaxis or...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts